Literature DB >> 23556048

Liver transplantation for recurrent hepatic adenoma.

Giovanni Vennarecci1, Roberto Santoro, Mario Antonini, Cecilia Ceribelli, Andrea Laurenzi, Enrico Moroni, Mirco Burocchi, Pasquale Lepiane, Giuseppe Maria Ettorre.   

Abstract

Hepatic adenoma (HA) is a rare indication for liver transplantation (LTx). So far 20 cases of LTx for HA are reported in PubMed. In rare cases HA presents as multiple hepatic adenomas or recurrent adenoma after initial liver resection and in such cases LTx is the only potential cure and prevents the risk of bleeding or cancer transformation into hepatocellular carcinoma. We report the case of a 56 years old lady who underwent a left hepatectomy for giant adenoma in 2005 and resection of segment V-VI for recurrence of liver adenoma in 2007. She developed a second recurrence of HA with 3 new lesions in the right liver in 2008. The patient underwent LTx. After 3 years the patient is alive with no evidence of disease. LTx is indicated in patients with HA in which resection is not technically feasible.

Entities:  

Keywords:  Immunosuppression; Liver adenoma; Liver resection; Liver transplantation; Recurrent disease

Year:  2013        PMID: 23556048      PMCID: PMC3612574          DOI: 10.4254/wjh.v5.i3.145

Source DB:  PubMed          Journal:  World J Hepatol


  18 in total

1.  Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences.

Authors:  S M van Aalten; T Terkivatan; R A de Man; D J van der Windt; N F M Kok; R Dwarkasing; J N M Ijzermans
Journal:  Dig Surg       Date:  2010-04-01       Impact factor: 2.588

2.  A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.

Authors:  Safi Dokmak; Valérie Paradis; Valérie Vilgrain; Alain Sauvanet; Olivier Farges; Dominique Valla; Pierre Bedossa; Jacques Belghiti
Journal:  Gastroenterology       Date:  2009-08-05       Impact factor: 22.682

3.  Rapid disappearance of hepatic adenoma after contraceptive withdrawal.

Authors:  P Aseni; C V Sansalone; C Sammartino; F D Benedetto; G Carrafiello; A Giacomoni; C Osio; M Vertemati; D Forti
Journal:  J Clin Gastroenterol       Date:  2001-09       Impact factor: 3.062

4.  Changing trends in malignant transformation of hepatocellular adenoma.

Authors:  Olivier Farges; Nelio Ferreira; Safi Dokmak; Jacques Belghiti; Pierre Bedossa; Valérie Paradis
Journal:  Gut       Date:  2011-01       Impact factor: 23.059

5.  Resection of presumed benign liver tumours.

Authors:  J Belghiti; D Pateron; Y Panis; V Vilgrain; J F Fléjou; J P Benhamou; F Fékété
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

6.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

7.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

8.  Liver transplantation for spontaneous intrapartum rupture of a hepatic adenoma.

Authors:  Roberto Santambrogio; Anna Maria Marconi; Andrea Pisani Ceretti; Mara Costa; Giorgio Rossi; Enrico Opocher
Journal:  Obstet Gynecol       Date:  2009-02       Impact factor: 7.661

9.  Liver adenomatosis: a rare indication for living donor liver transplantation.

Authors:  S Di Sandro; A O Slim; A Lauterio; A Giacomoni; I Mangoni; P Aseni; V Pirotta; A Aldumour; P Mihaylov; L De Carlis
Journal:  Transplant Proc       Date:  2009-05       Impact factor: 1.066

10.  Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas.

Authors:  Deha Erdogan; Otto M van Delden; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Nov-Dec       Impact factor: 2.740

View more
  6 in total

1.  Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit.

Authors:  Nicola de'Angelis; Riccardo Memeo; Julien Calderaro; Emanuele Felli; Chady Salloum; Philippe Compagnon; Alain Luciani; Alexis Laurent; Daniel Cherqui; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2014-05-23       Impact factor: 3.647

2.  miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.

Authors:  Zhong-Di Xiao; Chun-Yu Jiao; Hai-Tao Huang; Li-Jia He; Jiu-Jun Zhao; Zhao-Yang Lu; Lian-Xin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 3.  Hepatocellular adenoma: when and how to treat? Update of current evidence.

Authors:  Maarten G Thomeer; Mirelle Broker; Joanne Verheij; Michael Doukas; Turkan Terkivatan; Diederick Bijdevaate; Robert A De Man; Adriaan Moelker; Jan N IJzermans
Journal:  Therap Adv Gastroenterol       Date:  2016-09-28       Impact factor: 4.409

4.  Clinicopathological features and post-resection outcomes of hepatocellular adenoma.

Authors:  Sung-Min Kim; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Seung-Mo Hong
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-02-28

5.  Liver Transplantation for Hepatic Adenoma: A UNOS Database Analysis and Systematic Review of the Literature.

Authors:  Ioannis A Ziogas; Panagiotis T Tasoudis; Nikolaos Serifis; Sophoclis P Alexopoulos; Martin I Montenovo; Alexandra Shingina
Journal:  Transplant Direct       Date:  2022-01-05

6.  Liver Transplantation for Treatment of Unresectable Spontaneous Ruptured Hepatocellular Adenoma: A Rare Indication.

Authors:  Patrícia Rocha; Nuno Leal; Manuel Barbosa; Janine De Resende; Pedro Rodrigues
Journal:  Cureus       Date:  2022-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.